Peritoneal dialysis care by using artificial intelligence (AI) and information technology (IT) in Japan and expectations for the future

Author:

Nakamoto Hidetomo,Aoyagi Ryutaro,Kusano Takeru,Kobayashi Takehito,Ryuzaki Munekazu

Abstract

AbstractIn 2022, the government approved the telemedicine system for peritoneal dialysis (PD) in Japan in the form of medical fees. In 2000, we completed a telemedicine system for PD using an automatic peritoneal dialysis (APD) machine. We have published several papers and obtained international patents, but it was impossible to spread them. In recent years, the use of the internet and the spread of COVID-19 have led to the recognition of the importance of telemedicine, leading to the approval of medical fees for telemedicine in PD treatment in Japan. This change is believed to indicate the future direction of PD medicine. However, the current systems are still inadequate. They are difficult to use, and it is difficult for older patients to master their use. Therefore, we hope to develop a system that is easy to use, even for older patients. The new system is a wristwatch or mobile phone monitoring system for blood pressure, heart rate, partial pressure of oxygen, and electrocardiogram. However, development competition for such a mechanism occurs worldwide. Soon, the use of telemedicine in home medical care is expected to become a common practice. It is expected that the telemedicine system, which has been approved for patients using APD in Japan, will also be available for patients undergoing PD other than APD and patients undergoing home hemodialysis in the future. One important feature would be cooperation among doctors, nurses, clinical engineers, medical care teams, and primary care physicians. Advances in artificial intelligence (AI) and information technology (IT) are expected to significantly expand PD medical care in the future. This review is focused on the use of AI and IT for PD medical care in Japan and expectations for the future.

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Urology,Nephrology

Reference11 articles.

1. Nakamoto H, Hatta M, Tanaka A, Moriwaki K, Oohama K, Kagawa K, Wada K, Suzuki H. Telemedicine system for home automated peritoneal dialysis. Adv Perit Dial. 2000;16:191–4.

2. Nakamoto H, Kawamoto A, Tanabe Y, Nakagawa Y, Nishida E, Akiba T, Suzuki H. Telemedicine system for CAPD patients by using cellular phone. Adv Perit Dial. 2003;19:124–9.

3. Nakamoto H, Nishida E, Ryuzaki M, Sone M, Yoshimoto M, Itagaki K. Blood pressure monitoring system in-patients on CAPD by using cellular telephone. Adv Perit Dial. 2004;20:105–10.

4. Nakamoto H. Telemedicine system in patients on CAPD. Perit Dial Int. 2007;Suppl 2:S21–6.

5. Ryuzaki M, Nakamoto H, Nishida E, Sone M, Nakajima S, Yoshimoto M, Suzuki Y, Itagaki K. Crossover study of amlodipine versus nifedipine CR with home blood pressure monitoring via cellular phone: Internet-mediated open-label crossover trial of calcium channel blockers for hypertension (I-TECHO trial). J Hypertens. 2007;25:2352–8.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3